Title:
ヘプラペプチドの製剤
Document Type and Number:
Japanese Patent JP6537504
Kind Code:
B2
Abstract:
The present disclosure provides a drug formulation for hepalatide, comprising hepalatide and a buffer salt, and containing or not containing an osmotic regulator and/or an excipient.
More Like This:
Inventors:
Liu Hiroshi
Application Number:
JP2016522216A
Publication Date:
July 03, 2019
Filing Date:
June 24, 2014
Export Citation:
Assignee:
SHANGHAI HEP PHARMACEUTICAL CO., LTD.
International Classes:
A61K9/08; A61K38/16; A61K9/19; A61K47/02; A61K47/24; A61K47/26; A61K47/36; A61P1/16; A61P31/20
Domestic Patent References:
| JP2003502027A | ||||
| JP2006518727A | ||||
| JP2012505909A | ||||
| JP4330280A | ||||
| JP5345729A | ||||
| JP3504721A | ||||
| JP8245418A | ||||
| JP2008503240A |
Foreign References:
| CN102241744A |
Other References:
岡田 雅人,宮崎 香 編集,無敵のバイオテクニカルシリーズ 改訂 タンパク質実験ノート 上 抽出と分離精製,株式会社 羊土社,2002年 3月20日,p.17-22
Attorney, Agent or Firm:
Fukami patent office